Wow!7 Apr 2020 13:39
A drug that was being developed in the UK for asthma is being fast-tracked into trials for Covid-19.
Called SNG001, it was given rapid approval in March by the Medicines and Healthcare products Regulatory Agency (MHRA) after the World Health Organisation said it might be useful in fighting the virus.
A trial of 100 Covid-19 patients is getting under way at University Hospital Southampton. Delivered by inhaler, the drug raises levels of interferon beta-1, a protein that dictates the immune system's response to viruses that affect the lungs.